版本:
中国

BRIEF-Vical reports outcome of Phase 1 trial of VL-2397

May 2 Vical Inc

* Vical highlights successful outcome of Phase 1 trial of VL-2397 novel antifungal during its research and development day Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐